MAPT and Alzheimer disease: Beyond tau and 14-3-3 proteins, we also identified elevated levels of SMOC1, MIF, NRG1, and UCHL1 in the CSF of AD patients—findings that were corroborated by other proteomic and immunoassay-based studies, including those using Olink (8, 38).